Evercore ISI removed Cardinal Health from its ‘Tactical Outperform” list while keeping an In Line rating on the shares and raising the firm’s price target on Cardinal Health to $115 from $105. The stock is up today largely on the better-than-feared Global Medical Products and Distribution outlook, and FY25 now moves into execution mode, the analyst tells investors in a research note.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CAH:
- CAH Earnings: Cardinal Rises on Raised Outlook & Robust Q4 Results
- Options Volatility and Implied Earnings Moves Today, August 14, 2024
- Cardinal Health Executives to Discuss Annual Financial Results
- Cardinal Health raises FY25 EPS view to $7.55-$7.70 from at least $7.50
- Cardinal Health Reports Fourth Quarter and Fiscal Year 2024 Results and Raises Fiscal Year 2025 Guidance